c.niemel

TL3 Regular · Pau, FR

Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.

Joined 13 January 2025 · last posted 15h

148 posts, newest first. Showing up to 150.

Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #13 · Devices › Syringes & needles · 27 Jul 2026 · 4 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #20 · Compounds › Semaglutide · 27 Jul 2026 · 20 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #23 · Clinical › Comorbidities · 27 Jul 2026 · 0 likes Post #21 describes the usual case. This is about the unusual one. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people…
Private prescribing in the UK: what is actually involved Replied, post #75 · Regional › UK & Ireland · 25 Jul 2026 · 0 likes Coming back to post #73, because the follow-up matters more than the original answer. I changed my mind about private prescribing after someone here asked me for the…
Tracking a shortage from primary sources rather than rumour Replied, post #108 · Access › Shortages · 17 Jul 2026 · 25 likes Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is frustrating and is not evidence of anything.
Micro-titration: a disputed topic, argued properly Replied, post #105 · Practice › Dosing & titration · 15 Jul 2026 · 7 likes A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day…
Journal club: LEADER as the historical anchor Replied, post #103 · Evidence › Journal club · 12 Jul 2026 · 6 likes That is a cleaner way of putting what I was circling around.
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #28 · Clinical › Comorbidities · 11 Jul 2026 · 0 likes The most useful thing anyone has posted about Osteoarthritis and mechanical versus metabolic in this category was a table of what had been measured and by whom. That is…
Revisiting: The best-written scientific paper you have read Replied, post #81 · Lounge › Off topic · 10 Jul 2026 · 30 likes An update on my earlier best-written scientific paper post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #54 · Clinical › Bloodwork · 9 Jul 2026 · 0 likes This follows post #51 rather than contradicting it. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down…
How shortages have affected compounding permissions Replied, post #23 · Access › Shortages · 8 Jul 2026 · 0 likes Shortages end and the notices are updated. Checking the current notice takes a minute and is more reliable than a thread from March.
Comparing documentation quality across the directory, tabulated Replied, post #9 · Sourcing › Vendor reports · 8 Jul 2026 · 0 likes The service matters to the interpretation. A documentation review and a chromatographic assay answer different questions and both are worth filing. The confident…
Programming during a large energy deficit Replied, post #33 · Nutrition & Training › Resistance training · 6 Jul 2026 · 9 likes Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding. Expecting continuous progress during weight loss is unrealistic. A…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #49 · Access › International · 1 Jul 2026 · 6 likes Same experience here, different supplier, so it is at least not unique to one of them.
Revisiting: The best-written scientific paper you have read Replied, post #62 · Lounge › Off topic · 30 Jun 2026 · 31 likes A methods point on best-written scientific paper rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
Follow-up: Reading an interaction checker output critically Replied, post #25 · Practice › Interactions · 30 Jun 2026 · 32 likes Answering the question post #23 raises rather than the one it answers. Insulin and sulfonylureas are the interaction that the labelling in this class flags most…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #44 · Analytics › HPLC & UHPLC · 17 Jun 2026 · 0 likes A shallow gradient resolves close-eluting species that a steep one merges. Two honest laboratories running different gradients can report genuinely different purities…
Racemisation and why it is invisible to a mass measurement Replied, post #97 · Analytics › Impurities & related substances · 14 Jun 2026 · 0 likes Worth separating two things that post #93 runs together. Relative response factors mean impurities are not detected in proportion to how much of them is present. A one…
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #20 · Start Here › Welcome · 12 Jun 2026 · 31 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Journal club: LEADER as the historical anchor Replied, post #88 · Evidence › Journal club · 12 Jun 2026 · 2 likes Building on post #86 rather than restating it. Where the LEADER discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it…
I joined for one answer and stayed for a year — what changed my mind Replied, post #16 · Start Here › Welcome · 11 Jun 2026 · 8 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #20 · Compounds › Secretagogues & GH axis · 9 Jun 2026 · 0 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. Growth hormone secretagogues act on the ghrelin receptor or on the growth hormone…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #24 · Evidence › Journal club · 9 Jun 2026 · 25 likes Post #23 answers the question as asked. The question underneath it is different. The baseline characteristics table is the single most useful page for the questions…
Coming back to: A structured critique template this community uses Replied, post #27 · Evidence › Study critique · 6 Jun 2026 · 4 likes Adding the measurement that post #26 says would settle it. Source for the structured critique template figure, since it was asked for. It is in the discussion rather…
Why this subcategory is stricter about sourcing than most Replied, post #35 · Compounds › Secretagogues & GH axis · 27 May 2026 · 0 likes Post #33 and I disagree about the size of the effect, not about the direction. On analysis: these are short peptides and generally straightforward chromatographically,…
Prescription portability between countries Replied, post #42 · Access › International · 24 May 2026 · 7 likes Taking post #41 at face value and following it one step further. Temperature-controlled material and long-haul travel is a practical problem with practical solutions,…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #38 · Practice › Storage & stability · 22 May 2026 · 1 like Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. That has held every time I have looked,…
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #5 · Clinical › Bloodwork · 21 May 2026 · 14 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #20 · Evidence › Journal club · 15 May 2026 · 2 likes Something worth flagging about STEP 1: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #110 · Devices › Syringes & needles · 11 May 2026 · 0 likes Narrowing post #107, because the general version has more than one answer. Sharps containers are a legal requirement for disposal in several jurisdictions and a…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #42 · Practice › Reconstitution · 11 May 2026 · 0 likes Where I have landed on 5 mg vial, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed…
Stepping down deliberately, and how to do it without losing progress Replied, post #102 · Practice › Dosing & titration · 1 May 2026 · 1 like Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #14 · Analytics › COA interpretation · 30 Apr 2026 · 2 likes Where I part company with post #12, and it is a narrow parting. Reframing field-by-field walk through a certificate slightly, because I think the disagreement is about…
Does a peptide degrade silently, with no visual change? Replied, post #17 · Practice › Storage & stability · 28 Apr 2026 · 27 likes Agreed on peptide, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the…
CJC-1295 with and without DAC: what the modification does Replied, post #41 · Compounds › Secretagogues & GH axis · 24 Apr 2026 · 0 likes Taking post #38 at face value and following it one step further. CJC-1295 exists in two forms in circulation — with and without the drug affinity complex — and they…
Journal club: is percentage weight change the right endpoint? Replied, post #96 · Evidence › Journal club · 23 Apr 2026 · 10 likes Right — I had this wrong and I am glad to have read it before it mattered.
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #98 · Sourcing › Vendor reports · 23 Apr 2026 · 0 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. Flagging that the sources on…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #46 · Sourcing › Logistics · 19 Apr 2026 · 4 likes Taking post #44 at face value and following it one step further. On Regional warehouse stock versus direct I would separate what is worth knowing from what is worth…
Citation sweep results: how many references did not say what was claimed Replied, post #77 · Meta › Wiki maintenance · 13 Apr 2026 · 9 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. I am confident about the direction and much less about the…
List price versus negotiated price versus what you pay Replied, post #41 · Access › Pricing · 11 Apr 2026 · 17 likes Price differences within a market are usually about scale, documentation and logistics rather than about anything mysterious.
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #36 · Evidence › Trials · 8 Apr 2026 · 0 likes Post #33 answers the question as asked. The question underneath it is different. Careful with the language on Subgroup analyses. "Not detected" and "not present" are…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #14 · Devices › Syringes & needles · 7 Apr 2026 · 14 likes Taking post #11 at face value and following it one step further. Answering the 0.3 ml versus 0.5 ml question as asked, then the question I think is meant. As asked:…
Choosing which test to pay for, given a fixed budget Replied, post #58 · Sourcing › Independent verification · 7 Apr 2026 · 0 likes Narrowing post #55, because the general version has more than one answer. The record shows what was measured. Everything beyond that is inference and this site tries to…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #18 · Clinical › Bloodwork · 4 Apr 2026 · 0 likes Picking up post #15: that is the part I would want checked first. A trend needs at least three points to be a trend. Two points are a line and a line through noise is…
Revisiting: Body image changing more slowly than the body Replied, post #2 · Wellbeing › Mental health · 29 Mar 2026 · 23 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #122 · Access › Pricing · 21 Mar 2026 · 1 like Worth separating two things that post #121 runs together. Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies…
Personal import allowances, compared — a second dataset Replied, post #86 · Access › International · 16 Mar 2026 · 26 likes Confirming post #85 from a second method, which matters more than confirming it from a second person. Customs and import outcomes: different routes have different…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #61 · Compounds › Repair & healing peptides · 14 Mar 2026 · 24 likes I think the Reading a preclinical wound-healing model question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Revisiting: Maintainer handover: how it works Replied, post #36 · Meta › Wiki maintenance · 7 Mar 2026 · 0 likes I would call the community position on Maintainer handover likely rather than established, and I would be comfortable defending that hedge.
Grapefruit: why this class is not the class that cares Replied, post #8 · Practice › Interactions · 3 Mar 2026 · 0 likes A request rather than an answer: could whoever has the primary source for grapefruit post it? I have seen the claim three times this month and each version had lost a…
Bioimpedance and hydration: why the number moves Replied, post #11 · Outcomes › Body composition · 25 Feb 2026 · 0 likes Answering the bioimpedance and hydration question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how…
Forced degradation studies: designing one that is informative Replied, post #11 · Analytics › Method validation · 24 Feb 2026 · 0 likes Having read the whole forced degradation studies thread before replying: the question in the first post has not actually been answered yet, and three of us have…
Measurement error in a self-reported exposure Replied, post #16 · Evidence › Study critique · 22 Feb 2026 · 0 likes Whatever the answer on measurement error turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #17 · Compounds › Tirzepatide · 16 Feb 2026 · 15 likes Narrowing post #14, because the general version has more than one answer. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #26 · Outcomes › Body composition · 11 Feb 2026 · 0 likes If you are new and reading this thread for the answer to Lean mass preservation: the answer is conditional, the conditions are in the third reply, and the rest of the…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #55 · Documentation › Wiki requests · 25 Jan 2026 · 0 likes Picking up post #54: that is the part I would want checked first. Format suggestions: if you think a maintained page could be clearer in its presentation (different…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #17 · Analytics › Mass spectrometry · 25 Jan 2026 · 16 likes An observation about Adducts that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not Started this topic · Compounds › Semaglutide · 23 Jan 2026 · 0 likes Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not Writing it up because I had to work it out twice and would rather nobody else…
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #23 · Data & Tools › Calculators · 15 Jan 2026 · 13 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #51 · Start Here › How to Ask · 11 Jan 2026 · 7 likes Picking up post #48: that is the part I would want checked first. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
A partial dose because the pen emptied mid-injection Replied, post #105 · Practice › Administration · 10 Jan 2026 · 6 likes Adding the measurement that post #103 says would settle it. Reading this partial dose because the pen thread as someone who came in with a fixed view: the third and…
Reading an interaction checker output critically Replied, post #88 · Practice › Interactions · 10 Jan 2026 · 4 likes The arithmetic on reading an interaction checker output is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #10 · Clinical › Special populations · 9 Jan 2026 · 2 likes Coming back to post #6, because the follow-up matters more than the original answer. I would keep pregnancy and pregnancy planning and the decision it usually gets used…
When to stop reading forums, including this one Replied, post #66 · Wellbeing › Mental health · 24 Dec 2025 · 0 likes Narrowing post #65, because the general version has more than one answer. Motivation and expectation: starting with clear motivation and realistic expectations about…
The decimal-point error, and the habit that catches it Replied, post #84 · Practice › Reconstitution · 17 Dec 2025 · 13 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
Tracking a preprint to publication: a worked example Replied, post #136 · Evidence › Preprints · 13 Dec 2025 · 0 likes Post #134 is the version of this I will quote in future. One addition. If you are new and reading this thread for the answer to tracking a preprint: the answer is…
Prescription requirements and telehealth models Replied, post #63 · Sourcing › Regulatory · 12 Dec 2025 · 14 likes Clear enough that I do not think I have a follow-up, which is unusual.
Prescription requirements and telehealth models Replied, post #56 · Sourcing › Regulatory · 9 Dec 2025 · 5 likes Post #52 and I disagree about the size of the effect, not about the direction. Marking my uncertainty on prescription requirements and telehealth models explicitly. I…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #31 · Analytics › Method validation · 7 Dec 2025 · 0 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. The evidence for this is…
Amylin receptor signalling and satiety — what changed since Replied, post #2 · Pharmacology › Receptor biology · 5 Dec 2025 · 0 likes In vitro potency and clinical potency are related by a long chain of assumptions. A compound more potent at the receptor is not necessarily more effective at a…
Journal club: the retatrutide phase 2 obesity paper Replied, post #10 · Evidence › Journal club · 24 Nov 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
LOD and LOQ: definitions people get wrong Replied, post #3 · Analytics › Method validation · 22 Nov 2025 · 22 likes I read the opening post twice before replying, because I had assumed the opposite. Limits of detection and quantitation: LOD is the lowest concentration that produces a…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #75 · Analytics › COA interpretation · 21 Nov 2025 · 22 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Lurking for two months before posting: was that the right call? Replied, post #60 · Start Here › Welcome · 20 Nov 2025 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
The headache that turns out to be dehydration Replied, post #59 · Nutrition & Training › Hydration & electrolytes · 16 Nov 2025 · 2 likes Picking up post #58: that is the part I would want checked first. Where a laboratory result exists, quoting it with the reference interval makes the discussion…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #6 · Compounds › Retatrutide · 16 Nov 2025 · 7 likes Adding the measurement that post #3 says would settle it. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #61 · Compounds › Oral incretins · 14 Nov 2025 · 1 like Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
Where to report an adverse event officially, by region — a second dataset Replied, post #124 · Safety › Adverse events · 12 Nov 2025 · 3 likes Following this. I have the same question and no better information than the first post.
A parcel that arrived warm: a decision process, not a verdict Replied, post #115 · Practice › Storage & stability · 1 Nov 2025 · 5 likes On post #113 — agreed on the reasoning, with one qualification. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #74 · Start Here › How to Ask · 23 Oct 2025 · 0 likes Confirming post #73 from a second method, which matters more than confirming it from a second person. Timeline questions need the timeline. Dates, in order, with what…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #8 · Practice › Side effects · 22 Oct 2025 · 1 like The version of Constipation management that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Tracking that stops updating and then resumes Replied, post #36 · Sourcing › Logistics · 15 Oct 2025 · 19 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Comparing my trajectory with the trial curves, carefully Replied, post #56 · Outcomes › Progress reports · 2 Oct 2025 · 31 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding. Take the reasoning and check the arithmetic; I do…
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #16 · Evidence › Journal club · 26 Sep 2025 · 9 likes Practical note on step-hfpef and symptom endpoints: write down what you expect before you look. The number of times I have found what I went looking for is higher than…
Severe abdominal pain: why this is not a forum question — one year on Replied, post #3 · Safety › Adverse events · 24 Sep 2025 · 1 like No notes. Posting so the count is not one.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #121 · Evidence › Study critique · 16 Sep 2025 · 23 likes Picking up post #118: that is the part I would want checked first. Practical answer on Reverse causation, since the theoretical one is upthread: do the simplest check…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #74 · Devices › Cold chain · 9 Sep 2025 · 26 likes Airline travel was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #19 · Clinical › Special populations · 8 Sep 2025 · 12 likes Body weight at the extremes of the studied range affects exposure and the trials rarely reported enough to say by how much.
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #27 · Compounds › Tirzepatide · 28 Aug 2025 · 14 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
Asking about a compound your prescriber has not heard of Replied, post #136 · Clinical › Prescriber conversations · 24 Aug 2025 · 15 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. Take the reasoning and check…
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #22 · Start Here › Welcome · 6 Aug 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
How to research a compound with no human data without deceiving yourself Replied, post #35 · Compounds › Other compounds · 31 Jul 2025 · 30 likes Solubility varies far more across this subcategory than within the incretins. A compound that needs a specific diluent or a specific pH is not being difficult; it has a…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #86 · Compounds › Semaglutide · 25 Jul 2025 · 30 likes Nothing to add, except that this is the answer I would give if asked.
Immortal time bias in a claims-database study Replied, post #6 · Evidence › Study critique · 25 Jul 2025 · 9 likes Narrowing post #3, because the general version has more than one answer. Reframing immortal time bias slightly, because I think the disagreement is about the question…
Why the timeline is on the right and not the left Replied, post #45 · Meta › Site feedback · 24 Jul 2025 · 0 likes Where I would push back on the timeline consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
A preprint whose numbers changed substantially at publication Replied, post #2 · Evidence › Preprints · 24 Jul 2025 · 28 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Server repositories: medRxiv for medicine, bioRxiv for…
Asking about a compound your prescriber has not heard of Replied, post #99 · Clinical › Prescriber conversations · 19 Jul 2025 · 30 likes Agreed on all of that, and I have nothing to add to it.
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #15 · Compounds › Retatrutide · 18 Jul 2025 · 8 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #64 · Compounds › Oral incretins · 14 Jul 2025 · 1 like I read post #63 twice before replying, because I had assumed the opposite. Anyone comparing published oral and injectable efficacy should check whether the comparison…
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #12 · Compounds › Secretagogues & GH axis · 6 Jul 2025 · 4 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
Anxiety in the first weeks: drug, situation, or both Replied, post #112 · Wellbeing › Mental health · 5 Jul 2025 · 0 likes Sensible. I would want the same detail before I acted on it either.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #27 · Access › Insurance & coverage · 27 Jun 2025 · 13 likes Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose. I have kept the units in throughout, for the obvious reason.
Consistent declarations and why they matter more than clever ones — a second dataset Replied, post #2 · Sourcing › Logistics · 21 Jun 2025 · 16 likes Useful. I have added it to my own notes with the date on it.
Half-life, steady state, and accumulation worked through Replied, post #87 · Pharmacology › Pharmacokinetics · 9 Jun 2025 · 16 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
A claim built entirely on a subgroup analysis Replied, post #69 · Evidence › Study critique · 1 Jun 2025 · 18 likes Checked the claim built claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
Needle changes between doses on a reusable pen Replied, post #11 · Devices › Pens & autoinjectors · 29 May 2025 · 30 likes Nothing here is medical advice, and pen technique is the single easiest thing to have demonstrated in person rather than learned from a description.
Pre-registering a personal experiment, seriously Replied, post #31 · Research Methods › N-of-1 designs · 28 May 2025 · 9 likes Practical answer on pre-registering a personal experiment, since the theoretical one is upthread: do the simplest check first, write down the result, and only then…
Why plausible mechanism is not evidence of effect Replied, post #11 · Compounds › Repair & healing peptides · 21 May 2025 · 8 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #4 · Data & Tools › Calculators · 14 May 2025 · 0 likes A tool that refuses to give an answer when the result falls below one graduation is doing something useful. Most just print the number. The number is defensible. The…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #14 · Compounds › Repair & healing peptides · 14 May 2025 · 0 likes TB-500 and thymosin beta-4 is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #31 · Clinical › Comorbidities · 10 May 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Units, standards, and other things that quietly hold the world together Replied, post #39 · Lounge › Off topic · 7 May 2025 · 28 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
Triple agonism: additive, synergistic, or neither? Replied, post #42 · Compounds › Retatrutide · 3 May 2025 · 0 likes Post #41 is the version of this I will quote in future. One addition. Retatrutide is investigational. Anything obtained outside a trial is by definition…
Requesting a page: what makes a good request Replied, post #63 · Documentation › Wiki requests · 19 Apr 2025 · 0 likes On post #61 — agreed on the reasoning, with one qualification. Say what would make the page wrong. A page whose failure conditions are stated is much easier to review…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #23 · Evidence › Journal club · 18 Apr 2025 · 4 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #10 · Practice › Administration · 11 Apr 2025 · 30 likes Narrowing post #9, because the general version has more than one answer. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip.…
A supplier that answers analytical questions with restated claims Replied, post #54 · Sourcing › Red flags · 9 Apr 2025 · 4 likes An unexplained discrepancy that the supplier declined to address is a legitimate thing to record, stated as exactly that and nothing more.
About the Secretagogues & GH axis category Replied, post #5 · Compounds › Secretagogues & GH axis · 2 Apr 2025 · 8 likes Research-use-only secretagogues are not approved for human use. That statement is doing real work in this subcategory, where the published evidence base is thinner than…
A certificate with no method stated: what can you conclude? Replied, post #17 · Analytics › COA interpretation · 1 Apr 2025 · 32 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Coverage for the indication versus for the drug — a second dataset Replied, post #49 · Access › Insurance & coverage · 28 Mar 2025 · 4 likes Coverage would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Counter-ion form: the field almost nobody reports — one year on Replied, post #35 · Analytics › COA interpretation · 28 Feb 2025 · 0 likes I read post #33 twice before replying, because I had assumed the opposite. Peptide content and chromatographic purity are separate determinations and a certificate that…
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #13 · Compounds › Secretagogues & GH axis · 22 Feb 2025 · 2 likes Building on post #10 rather than restating it. A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #42 · Access › International · 13 Feb 2025 · 16 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #5 · Clinical › Comorbidities · 17 Jan 2025 · 0 likes Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public. Somebody will have a better source than mine,…
Fixed versus detachable needles: the trade-offs Replied, post #107 · Devices › Syringes & needles · 12 Jan 2025 · 9 likes Whatever the answer on fixed versus detachable needles turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
Recovery when intake is low: what to cut first Replied, post #39 · Nutrition & Training › Resistance training · 12 Jan 2025 · 0 likes Agreed on recovery, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #145 · Practice › Dosing & titration · 9 Jan 2025 · 0 likes Narrowing post #144, because the general version has more than one answer. The four-week step is a trial convention, not a pharmacological constant. It is roughly four…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #55 · Sourcing › Regulatory · 1 Jan 2025 · 20 likes Coming back to post #53, because the follow-up matters more than the original answer. Where a claim about legality is made here, the useful follow-up is which…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #126 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes Post #122 describes the usual case. This is about the unusual one. Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #31 · Compounds › Secretagogues & GH axis · 24 Dec 2024 · 1 like Adding the measurement that post #30 says would settle it. Effects reported at the level of appetite are the most consistently described and the most mechanistically…
[2026 update] New subcategory: rationale and scope Replied, post #36 · Meta › Announcements · 1 Dec 2024 · 0 likes For anyone finding this later: the short answer on New subcategory is that it depends on one thing, and the rest of the thread is people identifying which thing.
What changed in 2026, by region Replied, post #3 · Access › International · 29 Nov 2024 · 5 likes If a claim about your region here is out of date, correcting it with a date and a source is the single most valuable post you can make. One of those cases where knowing…
Why "any advice?" is the least effective ending for a post Replied, post #83 · Start Here › How to Ask · 28 Nov 2024 · 14 likes Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question is an imposition.
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #26 · Clinical › Special populations · 24 Nov 2024 · 7 likes The useful distinction on Athletes in weight-category sports is between what was measured and what was inferred from it. Both end up in the same sentence and only one…
Washout with a one-week half-life: the arithmetic Replied, post #6 · Research Methods › N-of-1 designs · 22 Nov 2024 · 9 likes Post #3 is right about the mechanism and I think understates the practical bit. A rolling mean over several days is far more informative than any single reading for…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #40 · Compounds › Semaglutide · 8 Nov 2024 · 11 likes This follows post #39 rather than contradicting it. Answering the Semaglutide half-life question as asked, then the question I think is meant. As asked: yes, with the…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #98 · Analytics › COA interpretation · 28 Oct 2024 · 12 likes Noted, and I have changed what I was going to do on the strength of it.
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #7 · Compounds › Oral incretins · 24 Oct 2024 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Tablet integrity matters more than people expect for a formulation that depends on…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #51 · Analytics › Method validation · 13 Oct 2024 · 2 likes Post #49 answers the question as asked. The question underneath it is different. Specificity is the first question: does the method separate the analyte from everything…
Progressive overload when the scale is falling — one year on Replied, post #149 · Nutrition & Training › Resistance training · 11 Oct 2024 · 6 likes Small methodological point on Progressive overload: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Why we hide unevidenced fraud accusations and log the hiding Replied, post #5 · Sourcing › Red flags · 11 Oct 2024 · 0 likes I came in to disagree and I am leaving without a disagreement.
US compounding rules and how they changed Replied, post #18 · Regional › North America · 10 Oct 2024 · 6 likes Shortage status determines what compounding is permitted in some jurisdictions, which is why the availability question and the compounding question are linked. I would…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #4 · Access › Shortages · 8 Oct 2024 · 5 likes Taking the opening post at face value and following it one step further. Regional differences during a shortage are large, and a supply position in one country says…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #61 · Clinical › Bloodwork · 27 Sep 2024 · 0 likes Helpful, and short, which on this subject is harder than long.
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #44 · Compounds › Retatrutide · 18 Sep 2024 · 1 like Post #42 and I disagree about the size of the effect, not about the direction. If you are new and reading this thread for the answer to hepatic effects of glucagon…
Blind submission and why it changes minds Replied, post #56 · Sourcing › Independent verification · 8 Sep 2024 · 0 likes Blind submission sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
How to ask for a dose change without antagonising anyone Replied, post #18 · Clinical › Prescriber conversations · 24 Aug 2024 · 18 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Why I ask for the gradient before I discuss the number Replied, post #3 · Analytics › HPLC & UHPLC · 21 Jun 2024 · 0 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…